03.03.2015 Views

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical <strong>Criteria</strong> with Description, Diagnostic Findings and ICD-9-CM codes<br />

DXCat Number: MUS04<br />

MultiStage: No<br />

DXCat Label: Eosinophilia Myalgia Syndrome Specificity: A<br />

Etiology: Toxicologic<br />

Stage Description Diagnostic findings ICD-9-CM Codes<br />

1.01 Eosinophilia Myalgia Syndrome Eosinophilia Myalgia Syndrome<br />

DX 7105, 725;<br />

OR eosinophilia:<br />

DX 2883 + DX 5183;<br />

AND eosinophilia persists ≥ 6mo.<br />

AND eosinophilic infiltration of heart [operative/pathology report]<br />

OR eosinophilic infiltration of liver [operative/pathology report]<br />

OR eosinophilic infiltration of spleen [operative/pathology report]<br />

OR eosinophilic infiltration of lungs [operative/pathology report]<br />

2.01 with peripheral neuropathy Stage 1.01<br />

AND peripheral neuropathy [EMG report]<br />

2.02 with deep vein thrombosis Stage 1.01-2.01<br />

AND DVT:<br />

2.03 with cardiac conduction abnormalities Stage 1.01-2.02<br />

AND cardiac conduction abnormalities:<br />

2.04 with aspiration pneumonia Stage 1.01-2.03<br />

AND aspiration pneumonia<br />

3.01 with pulmonary embolism Stage 2.02-2.04<br />

AND pulmonary embolism:<br />

3.02 with sepsis Stage 2.04-3.01<br />

AND sepsis:<br />

3.03 with respiratory failure Stage 2.02-3.02<br />

AND respiratory failure:<br />

3.04 with shock Stage 2.01-.3.03<br />

AND shock:<br />

4.00 with death Stage 2.01-3.04<br />

AND death<br />

STAGE 1.01 + (DX 33811, 33821,<br />

3569, 3577);<br />

STAGE 1.01-2.01 + GROUP DVT;<br />

STAGE 1.01-2.02 + GROUP<br />

COND_BBBS;<br />

STAGE 1.01-2.03 + DX 5070;<br />

STAGE 2.02-2.04 + GROUP<br />

PULMEMB;<br />

STAGE 2.04-3.01 + GROUP SEPSIS;<br />

STAGE 2.02-3.02 + GROUP<br />

RESP_FAIL;<br />

STAGE 2.02-3.03 + (GROUP<br />

SHOCKC OR GROUP SHOCKN) ;<br />

NO;<br />

References:<br />

Hellmann DB. Arthritis & musculoskeletal disorders. In: Tierney Jr LM, McPhee SJ, Papadakis MA, eds. Current Medical Diagnosis & Treatment. Stamford, CT: Appleton &<br />

Lange; 1998:774-824.<br />

Hertzman PA, Clauw DJ, Kaufman LD, et al. The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. Annals of Internal Medicine.<br />

1995;122(11):851-5.<br />

Sullivan EA, Kamb ML, Jones JL et al. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina. Archives of Internal Medicine.<br />

1996;156(9):973-9.<br />

Thursday, January 07, 2010 9:22:32 AM<br />

©2010 Thomson Reuters. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!